Please login to the form below

Not currently logged in
Email:
Password:

Pfizer's Robert Clark to move to Novo Nordisk

Will join firm’s US operations as vice president of regulatory affairs

Novo Nordisk has appointed Robert Clark as vice president of regulatory affairs in a role that will see him lead the Danish pharma company's US regulatory team.

He will also be tasked with maintaining “relationships with key individuals and agencies outside of Novo Nordisk that play a specific role in the US Food and Drug Administration's (FDA) review and approval process”, Novo said.

Clark will join the company on May 14 from Pfizer, where he was US regulatory strategy head, leading or supporting approvals of new cardiovascular, endocrine, women's health and anti-infective medicines.

"Bob is bringing 27 years of experience and knowledge of the global and US regulatory environment, and it's that know-how we require for an increasingly complex pharmaceutical marketplace," said Anne Philips, corporate vice president of clinical development, medical and regulatory affairs at Novo Nordisk.

"Novo Nordisk has one of the most promising diabetes pipelines in the industry, and having a respected leader known to regulatory authorities will help us achieve our ongoing mission to bring new therapies to patients."

9th May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics